Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ganesh Benzoplast Ltd. Capital/Financing Update 2023

Nov 7, 2023

61206_rns_2023-11-07_f710e0f8-8cb5-4d01-9b6a-9c8c56355aa7.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [596 x 137] intentionally omitted <==

Date: November 07, 2023

To

The General Manager,
Department
of
Corporate
Services

Corporate Relations Department,
BSE Limited,
Pheeroze Jeejeebhoy Towers,
Dalal Street, Fort,
Mumbai – 400 001.
Scrip ID: 500153
The Manager,
Listing Department
National Stock Exchange of India Limited
Exchange Plaza, 5th Floor,
Plot No. C/1, G-Block, Bandra Kurla
Complex,
Bandra (E), Mumbai – 400051
Scrip ID: GANESHBE

Dear Sir/ Madam,

Sub: Statement of deviation(s) or variation(s) under Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019

Pursuant to the Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 please note that there is no deviation/ variation in the utilization of proceeds as mentioned in the objects stated in the Preferential Issue of Warrants convertible into Equity Shares.

In terms of SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, enclosed find herewith the Statement of NIL deviation(s) or variation(s) for the quarter ended September 30, 2023.

We request you to kindly take the above information on your record.

Thanking you, Yours Faithfully, For Ganesh Benzoplast Ltd.

Digitally signed by EKTA EKTA DHANDA DHANDA Date: 2023.11.07 15:14:41 +05'30'

Ekta Dhanda

Company Secretary & Compliance Officer

Encl: As Above

==> picture [452 x 10] intentionally omitted <==

Statement of Deviation/ Variation In utilisation of funds raised Statement of Deviation/ Variation In utilisation of funds raised Statement of Deviation/ Variation In utilisation of funds raised Statement of Deviation/ Variation In utilisation of funds raised Statement of Deviation/ Variation In utilisation of funds raised Statement of Deviation/ Variation In utilisation of funds raised
Name of listed entity GANESH BENZOPLAST LIMITED
Mode of Fund Raising Preferential Issue of Warrants Convertible into Equity Shares*
Date of Raising Funds 27-07-2023
Amount Raised Rupees 30.13 crores
Report filed for Quarter ended September 30, 2023
Monitoring Agency Not Applicable
Monitoring Agency Name, if applicable Not Applicable
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms
of a contract or objects, which was approved by the
shareholders
Not Applicable
If Yes, Date of shareholder Approval Not Applicable
Explanation for the Deviation / Variation Not Applicable
Comments of the Audit Committee after review N IL
Comments of the auditors,if any N IL
Objects for which funds have been raised and where
there has been a deviation, in the following table
Original Object Modified
Object, if any
Original
Allocation
Modified
allocation, if
any
Funds
Utilised as on
30.09.2023
Amount of
deviation/
Variation for
the
quarter
according
to applicable
~~object~~
Remarks
if any
Expansion and General business requirements Not Applicable Rs. 30.13
crores
Not
Applicable
Rs. 30.13
crores
Not Applicble
(a) Deviation in the objects or purposes for which the funds have be
(b) Deviation in the amount of funds actually utilized as against wha
(c) Change in terms of a contract referred to in the fund raising docu
Deviation or variation could mean:
en raised or
t was originally discl
ment i.e. prospectu
osed or
s, letter of offer,
etc.

*Note: The Company Issued 60,00,000 equity warrants convertible into equal number of equity share at a price of Rs. 103/- each on preferential basis to the 34 investors belongs to nonpromoter group on March, 17, 2022 and On 27th july, 2023, 10 warrant holders exercised the option and the Company allotted 29,25,000(Twenty Nine Lacs Twenty Five Thousand only) Equity Shares of the face value of Rs. 1/- each at an issue price of Rs. 103/- (including a premium of Rs. 102/- per share), fully paid for 29,25,000 warrants held by them.

EKTA Digitally signed by EKTA DHANDA DHANDA Date: 2023.11.07 15:15:14 +05'30'